NDC 0061-0089 - Posatex

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0061-0089
Package NDCs from labels
0061-0089-01, 0061-0089-02, 0061-0089-03
Manufacturer
Merck Sharp & Dohme Corp.
Effective date
2024-10-29
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Posatex - Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp.2024-10-29PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0061-0089-01Posatex1 in 1 CARTONSUSPENSION19
0061-0089-01Posatex7.5 g in 1 BOTTLE, PLASTICSUSPENSION7.59
0061-0089-02Posatex1 in 1 CARTONSUSPENSION19
0061-0089-02Posatex15 g in 1 BOTTLE, PLASTICSUSPENSION159
0061-0089-03Posatex30 g in 1 BOTTLE, PLASTICSUSPENSION309
0061-0089-03Posatex1 in 1 CARTONSUSPENSION19

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0061-0089POSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [MERCK SHARP & DOHME CORP.]96 package rows20241031_f64232d7-e904-45d5-924d-07850f9c3e3d.zip

DailyMed Socrata Ingredients#

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 4 · 70 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Mometasone FuroateMOMETASONE FUROATEA-S Medication Solutions9fe65193-b4d8-480b-89b3-178cd1b207132023-02-15Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
SinuvaMOMETASONE FUROATEIntersect ENT, Inc.e33c1b23-cdc6-4f64-94ba-24b0b42c09bf2023-01-26Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
POSACONAZOLEPOSACONAZOLE DELAYED-RELEASEChartwell RX, LLCf2baa339-75ff-4c03-8334-a88648f701f72022-12-20Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
PosaconazolePOSACONAZOLECamber Pharmaceuticals, Inc.573d89eb-05d8-4035-b406-6409f36ab7072022-12-17Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
PosaconazolePOSACONAZOLENorthStar RxLLC4de6d839-e4bd-405c-83c5-8efc6abd08292022-12-17Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
POSACONAZOLEPOSACONAZOLEBiocon Phama Inc.e0e8023a-3c82-e455-a57b-ccc0206ad1562022-04-27Warnings, Adverse reactionsExact identifier
unii: 6TK1G07BHZ
Mometasone FuroateMOMETASONE FUROATEProficient Rx LP47a60763-671e-413b-b962-f7f11ba2f4d72021-01-01Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEGlenmark Pharmaceuticals Inc., USA96eafc06-0354-49ca-a684-a77bb2afc8f52020-05-31Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEProficient Rx LPc08fcb0d-7fff-4d90-aeb8-e912b930bf3d2020-02-01Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R
Mometasone FuroateMOMETASONE FUROATEGlenmark Pharmaceuticals Inc., USA031283ed-988b-4698-8a2e-00f3d41c0f712019-07-09Warnings, Adverse reactionsExact identifier
unii: 04201GDN4R

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.